Product NDC: | 0091-4087 |
Proprietary Name: | VERELAN PM |
Non Proprietary Name: | verapamil hydrochloride |
Active Ingredient(s): | 300 mg/1 & nbsp; verapamil hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0091-4087 |
Labeler Name: | UCB, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020943 |
Marketing Category: | NDA |
Start Marketing Date: | 19981125 |
Package NDC: | 0091-4087-01 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0091-4087-01) |
NDC Code | 0091-4087-01 |
Proprietary Name | VERELAN PM |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0091-4087-01) |
Product NDC | 0091-4087 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | verapamil hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19981125 |
Marketing Category Name | NDA |
Labeler Name | UCB, Inc. |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |